Method

CAR T-cell immunotherapy

T lymphocytes engineered to express chimeric antigen receptors (CARs) that redirect cytotoxic activity toward cells expressing a defined surface antigen, used as a cellular immunotherapy.

AI-generated definition

Scholars using this

View all 12 scholars →

MH
Mohamad HamiehAssistant Professor of Immunology in Pediatrics
MH
Mohamad HamiehAssistant Professor of Immunology in Pediatrics
ML
Monica L GuzmanAssociate Professor of Pharmacology in Medicine
ML
Monica L GuzmanAssociate Professor of Pharmacology in Medicine
JF
Joshua FeinAssistant Professor of Medicine
JF
Joshua FeinAssistant Professor of Medicine
RS
Rajiv S. MaggeAssociate Professor of Clinical Neurology
RS
Rajiv S. MaggeAssociate Professor of Clinical Neurology
GG
Giorgio Ga. InghiramiProfessor of Pathology and Laboratory Medicine
GG
Giorgio Ga. InghiramiProfessor of Pathology and Laboratory Medicine
IM
Ileana MirandaAssistant Professor of Veterinary Medicine in Clinical Pathology and Laboratory Medicine
IM
Ileana MirandaAssistant Professor of Veterinary Medicine in Clinical Pathology and Laboratory Medicine

Spotlight

CAR T-cell immunotherapy

MHMohamad Hamieh VPVirginia Pascual

Immunity · 2026

CAR T-cell immunotherapy

MHMohamad Hamieh

Blood cancer discovery · 2026

CAR T-cell immunotherapy

IMIleana Miranda

Veterinary pathology · 2026

View all 15 publications →

CAR T-cell immunotherapy

Scholars using this

Spotlight

Publications

Publications

CAR T-cell immunotherapy

Scholars using this

Paving the road for CARs in pediatric autoimmune diseases.

Two Costimulations Are Better Than One: Role of Endogenous CD28 in 4-1BB CAR T Cells.

Pathology associated with human CAR T cell administration in NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice: A retrospective analysis.